Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
about
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndromePolycystic ovary syndrome (PCOS): metforminPolycystic ovary syndrome: chemical pharmacotherapy.Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.Thiazolinedione treatment in PCOS--an update.PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis.Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.
P2860
Q30384617-75C74AAB-76B8-43C6-AF71-D289AB6C550AQ35222108-788D1D6D-E090-4FD3-8DC6-7C546217A17AQ35639510-787AECE1-191E-46EA-BA71-C4ECED2C86A9Q36797776-6F9B9DD9-EB16-4EA4-9E41-BFCA8F963E0CQ37763184-BBF7727C-B4D9-4D67-B2BA-A1134DDE08C5Q37931976-82015FBE-1436-4704-B81C-25FA18555365Q38748199-D21D7DA0-1C5B-4F9A-85F2-B33C691C9A2FQ40386727-1A9EC35C-4142-44C8-9104-3A0F3CD02A76Q47222891-C18F8F53-966E-499D-8681-9F673A41537BQ51302512-3F1D0CC7-84D2-4CC1-A6B2-5A1821DBC3C2Q51752247-5B1310D9-863F-45A3-B19F-03E93B788A31Q55256140-D5BDD823-4533-449E-AFE3-B391A7644A68
P2860
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@en
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@nl
type
label
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@en
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@nl
prefLabel
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@en
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P1476
Effects of metformin and ethin ...... ith polycystic ovary syndrome.
@en
P2093
Yaoping Cao
Yiqing Zhu
Yunfei Jiang
P2860
P304
P356
10.1080/09513590802217027
P577
2008-07-01T00:00:00Z